| Biogen Inc. | 229.29 / -0.69% |
| Date/Time | 05/17 / 21:59 |
| Chg. / Chg.(%) | -1.59 / -0.69% |
| Bid | 229.16 / 1 |
| Ask | 229.28 / 1 |
| Open | 229.73 |
| Previous Close | 230.88 |
| High | 231.95 |
| Low | 228.16 |
| Volume [USD] | 16,872,936.61 |
| Volume [Units] | 115,872 |
| Price fixings | 685 |
| ISIN | US09062X1037 |
| Security | BIIB |
| Exchange | Cboe US |
| Type | Stock |
Other Exchanges
| Exchange | Last | Volume | |
|---|---|---|---|
| Lang & Schwa.. | 204.781 |  |
|
| NASDAQ | 229.2800 | |
1,893,279 |
| Cboe US | 229.29 | |
115,872 |
| IEX | 229.20 | |
56,182 |
| Mexico | 4,435.00 |  |
2,156 |
| London Inter.. | 231.08 | |
1,296 |
| TradeGate | 205.150 | |
434 |
| Xetra | 206.95 | |
341 |
| Frankfurt | 204.900 |  |
225 |
| Stuttgart | 207.500 | |
221 |
| Vienna Globa.. | 207.36 | |
0 |
| München | 204.65 | |
0 |
| Hamburg | 204.65 | |
0 |
| Düsseldorf | 204.80 | |
0 |
| Berlin | 206.35 | |
0 |
| Hannover | 204.65 | |
0 |
| SIX Swiss Ex.. | 230.74 | |
|
| gettex | 205.650 | |
News
- Nightstar Therapeutics PLC Shareholders Approve Scheme of Arrangement for Acquisition By Biogen at General Meeting and Court Meeting Held on 8 May 2019
05/08/2019 / 15:36 - GlobeNewswire - Biogen Presents Data at 2019 AAN Annual Meeting Affirming Longer-Term Safety and Durability of Treatment with SPINRAZA® (nusinersen)
05/06/2019 / 13:30 - GlobeNewswire - Biogen to Present New Interim Data from Its Phase 1/2 Clinical Study of Tofersen (BIIB067) for the Potential Treatment of a Subtype of Familial Amyotrophic Lateral Sclerosis (ALS)
05/01/2019 / 22:30 - GlobeNewswire - Biogen To Present Data At AAN Highlighting Its Innovative Marketed Treatments And Investigational Pipeline Programs For Complex Neurodegenerative Diseases
05/01/2019 / 13:30 - GlobeNewswire - Data Published in Neurology Show that Treatment with SPINRAZA® (nusinersen) Improved Motor Function and Provided Long-Term Benefit for Individuals with Later-Onset Spinal Muscular Atrophy
04/30/2019 / 13:33 - GlobeNewswire
Real-time